Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Medication to prevent osteoporotic fractures may hinder the repair of damaged tissue

News: Dec 28, 2017

A study at Sahlgrenska Academy has found that one of the most common medications to prevent osteoporitic fractures gives rise to previously unknown mineralization of bone cells. The discovery may be important for understanding the effect of medication on bone quality.

“This type of mineralization is not desirable in the long run,” Furqan A. Shah, PhD in Biomaterials Science, says. He is the principal author of an article that has been published in Nano Letters.

Along with Anders Palmquist, Associate Professor of Biomaterials Science, and colleagues at Uppsala University and McMaster University in Canada, Dr. Shah has taken a new approach to studying bone biopsies from eight patients. All of them had been treated with bisphosphonates, which are often prescribed to prevent osteoportic fractures.

Loss of quality

Advanced nanoanalytical electron microscopy enabled the researchers to perform detailed, high-resolution analyses of the crystals formed in the bone cavities that remain after normal cell death. No similar mineralization was detected in the bone tissue of healthy controls. Ordinary bone mineral filled their cavities instead.

“The crystals are not normal,” Dr. Shah says. “Even though there are hundreds of them in every cell, they are very large under these circumstances. In other words, they might have grown extraordinarily slowly in the cavities.”

When relatively large, more chemically stable and harder crystals form, continual development and rejuvenation of bone tissue are impaired and quality deteriorates.

A piece of the puzzle

“The study also demonstrates the importance of correlative analytical techniques that permit imaging in conjunction with detailed analysis of the crystal phase and chemical composition,” Associate Professor Palmquist says.

The authors emphasize that their research does not call prescription of bisphosphonates, which have been commonly used for many years, into question. Nevertheless, the discovery may be a key consideration when new medications are developed.

“We have found a piece of the puzzle that may help us better understand the mechanisms that influence bone quality and adverse effects of medication,” Associate Professor Palmquist says.

Title: Micrometer-Sized Magnesium Whitlockite Crystals in Micropetrosis of Bisphosphonate-Exposed Human Alveolar Bone

Contact: Furqan A. Shah and Anders Palmquist

BY:

Originally published on: sahlgrenska.gu.se

News

  • Valand Academy highlight artistic practice as a type of research

    [19 Oct 2018] Taking Place is a series of events organised and presented by artist-educators working in Fine Art at Valand Academy, University of Gothenburg. For two days a number of lectures and performances will highlight how processes and methods of research shape their individual works and their overall practices.

  • Lecture: The rise of the Central European Neolithic - as seen from the East and West European research

    [18 Oct 2018] Archaeologist Professor Eszter Bánffy has been appointed to hold this year's Felix Neubergh Lecture. The lecture will be held on October 30 at the University of Gothenburg in Vasaparken. Students, employees and interested public are welcome. The lecture is held in English.

  • New attention to women with painful vertebral compression fractures

    [8 Oct 2018] Older women who suffer vertebral fractures rarely attract the attention of health care providers. A dissertation at Sahlgrenska Academy throws new light on a group of individuals with chronic pain as a constant companion.

  • Nobel Peace Prize awarded for work against the use of sexual violence as a weapon of war

    [5 Oct 2018] The awarding of the Nobel Peace Prize to Dr Denis Mukwege and Yazidi activist Nadia Murad sends an important signal. 'It symbolises and brings attention to the importance of persistent efforts to end the use of sexual violence in wars and armed conflicts,' says Helena Lindholm, professor of peace and development research at the University of Gothenburg.

  • Risk of blindness among premature babies with low levels of blood platelets

    [5 Oct 2018] Premature babies with low levels of platelets (thrombocytes) in their blood run a greatly increased risk of being afflicted with a severe variation of retinopathy of prematurity (ROP), an eye disease that can cause blindness, according to a study published in the journal JCI Insight. In experiments on mice, injections of blood platelets reduce the pathological development of retinal vessels.

More news

Calendar

To the calendar

Page Manager: Webbredaktionen|Last update: 7/13/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?